RaySearch reports Q2 2026 results and outlook
Net sales fell 11% to SEK 272 million, while order intake rose 23%; RaySearch launched software updates and maintained its 2026 operating-margin target of at least 25%.
See the latest news and media coverage for RaySearch. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiation therapy and oncology software provider
raysearchlabs.comLast updated
In short: RaySearch reported lower Q2 sales with higher orders, released v2026 software, and expanded partnerships and global reach.
Net sales fell 11% to SEK 272 million, while order intake rose 23%; RaySearch launched software updates and maintained its 2026 operating-margin target of at least 25%.
Net sales expected at SEK 272M, operating profit SEK 28M, order intake SEK 296M, and free cash flow SEK 50M.
Net sales declined 20% due to currency and timing. The company maintains a 23% operating margin, raised long-term targets to 30% EBIT by 2028, and highlights strong demand for online adaptive solutions.
It highlights record net sales, clinical milestones in adaptive therapies and AI planning, financial performance, and sustainability progress.
Order intake increased by 23% to SEK 296 M (241) Net sales decreased by 11% to SEK 272 M (305), with organic growth of -8...
Earnings call RaySearch Laboratories delivered record Q3 2025 net sales of SEK 332 million, up 13% YoY, and a 44% increase in operating profit to...
The medical technology company Raysearch issues a profit warning for the second quarter. The share price plunges between 20 and 30 percent in heavy trading.
Order intake decreased by 13% to SEK 356 M (410)Net sales decreased by 12% to SEK 290 M (332), with organic growth of -5 %Operating...
Track RaySearch and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to RaySearch and other trending companies.